HIGHLIGHTS
- who: HDACs et al. from the University of Belgrade, Serbia Neurosciences (NIMHANS), India have published the research work: HDAC4 in cancer: A multitasking platform to drive not only epigenetic modi cations, in the Journal: (JOURNAL)
- what: The aim of this manuscript is to provide an updated overview of the recent progresses regarding the contribution of the epigenetic regulator HDAC4 to cancer development.
- how: This result is in agreement with the possible involvement of MEF2 family members in EMT (Su et_al 2016 Xiao L et_al 2021).
- future: Certainly further studies are needed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.